Chicago Board Option • Financial Services • Asset Management • US • USD
Franklin Genomic Advancements ETF (HELX) has a market capitalization of $17.26M and trades at $34.67. The 52-week range is 23.74-38.17.
The stock has a beta of 1.33, a last dividend of $0.1433, operates in the Financial Services sector.
Be the first to know when stocks drop below their intrinsic value.
